EMPLICITI® (elotuzumab) | Information for Healthcare Professionals EMPLICITI® (elotuzumab), when used with Pd or Rd, is a prescription treatment for certain adults with relapsed or refractory multiple myeloma. Please see Indication and Important Safety Information.
HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other life-threatening diseases (AL Amyloidosis).
Mozobil (plerixafor injection) | Official Patient Site Welcome to the official patient site for Mozobil (plerixafor injection), an FDA-approved medication for patients living with non‐Hodgkin''s lymphoma (NHL) or multiple myeloma (MM). See Important Safety Information.